Rapamycin carbonate esters as immuno-suppressant agents
AssigneeAmerican Home Products Corporation
InventorDavid C. Hu
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmerican Home Products Corporation
InventorDavid C. Hu
Estimating the term…
Carbonate esters with rapamycin at position 42 or positions 31 and 42 have been shown to have immunosuppressant properties and are useful in the treatment of transplant rejections and autoimmune diseases. These esters are represented by the formula below: ##STR1## wherein: R.sup.1 and R.sup.2 are independently H or --COOR.sup.3 but both R.sup.1 and R.sup.2 cannot be H, and R.sup.3 is C.sub.1 -C.sub.6 alkyl where 1 to 3 hydrogens may be replaced by fluorine, chlorine, bromine or iodine, C.sub.3 -C.sub.8 cycloalkyl, C.sub.2 -C.sub.6 alkenyl, or Ar--(CH.sub.2).sub.n -- where n is 0 to 6 and Ar is phenyl, phenyl substituted by fluorine, chlorine, bromine, iodine, trifluoromethyl, nitro, cyano, C.sub.1 -C.sub.6 alkyl or C.sub.1 -C.sub.6 alkoxy; pyridinyl, indolyl, quinolyl or furanyl; or a pharmaceutically acceptable salt thereof.
A compound according to the formula:
A method of treating organ and tissue transplant rejection which comprises administration to a warm-blooded animal in need thereof of a therapeutically effective amount of a compound according to the formula:
A method of treating autoimmune diseases which comprises administration to a warm-blooded animal in need thereof of a therapeutically effective amount of a compound according to the formula:
A pharmaceutical composition for the treatment of organ and tissue transplant rejection and autoimmune diseases which comprises a pharmaceutical carrier and an effective amount of a compound having the formula:
Dependencies are inferred from the claim text.